Undifferentiated Ovarian Carcinoma Terminated Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028876 (Undifferentiated Ovarian Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004221Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTreatment